Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

This development comes amid the recent halt of US financial support for developing countries, including Nigeria, which has ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

Yearly lenacapavir injection for HIV prevention shows safety and long-lasting effects, according to clinical trial results.

The Federal Government of Nigeria has allocated a record-breaking N700 billion to fight HIV/AIDS, tuberculosis (TB), malaria, and immunization, signaling a renewed commitment to tackling infectious ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

The World Health Organization chief said regardless of whether the US reinstates its funding, "other donors will need to step ...

As one of the most influential and successful actions in the global fight against AIDS, PEPFAR — short for the President’s Emergency Plan for AIDS Relief — long enjoyed the rarified air of ...

Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, ...

The 90-day foreign aid freeze, ordered by U.S. President Donald Trump after taking office on January 20, has upended the global supply chain for medical products to fight HIV and other diseases.

International health organizations and governments are collaborating to address urgent needs in combating diseases like ...